- 579
children with ADHD aged 7 to 9.9 years were randomized to receive medication
management consisting of methylphenidate, intensive behavioral treatment,
a combination of both, or standard community care over 14 months.1
- Medication
management began with methylphenidate TID dosing titrated to maximal
effect through monthly visits with pharmacotherapists.
- Behavioral
treatment included parent training in both group and individual weekly
sessions tapered over time, child-focused treatment with an 8-week summer
program, and school-based intervention with bi-weekly teacher consultation
and paraprofessional aides working with the child.
- In
family report of side effects in combined treatment and medication management
subjects, 35.9% reported none, 49.8% reported mild side effects, 11.4%
moderate, and 2.9% severe.
|